z-logo
open-access-imgOpen Access
Gemcitabine and cisplatin-based combination chemotherapy in advanced hepatocellular carcinoma: An Indian experience
Author(s) -
Shripad Brahmanand Pande,
DC Doval,
Keechilat Pavithran,
JB Sharma,
Рашми Ширали,
Amarnath Jena
Publication year - 2012
Publication title -
indian journal of medical and paediatric oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.229
H-Index - 22
eISSN - 0975-2129
pISSN - 0971-5851
DOI - 10.4103/0971-5851.96968
Subject(s) - gemcitabine , medicine , neutropenia , cisplatin , oncology , chemotherapy , gastroenterology , nausea , hepatocellular carcinoma
Gemcitabine, an anti-metabolite, has some activity in hepatocellular carcinoma (HCC) in terms of responses and median survival.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here